Please Note: This trial is no longer enrolling new participants
A study evaluating the pregnancy outcomes and safety of interrupting endocrine therapy for young women with endocrine responsive breast cancer who desire pregnancy(POSITIVE)
| Protocol No. | A221405/IBCSG48-POSITIVE | Scope | National |
|---|---|---|---|
| Principal Investigator | Tarah Ballinger | Treatment Type | Treatment |
| Age Group | Adult | Phase | NA |
